Factors affecting success and abstinence within a smoking cessation clinic: A one-year follow-up study in Turkey

INTRODUCTION: Successful smoking cessation requires personal, environmental and pharmacological support. In our clinic, pharmacological treatment lasts up to three months. In this study, we aimed to investigate smoking cessation rates, the effects of follow-up visits and pharmacological therapies on smoking cessation in our smoking cessation clinic for one year. METHODS: Our study included 505 patient files that were randomly selected from the 5271 patients who were admitted to our outpatient clinic for smoking cessation in 2015–2016 and at least one year has passed from treatment initiation. Patients, who agreed to participate in this study, provided information on their smoking cessation status, treatment duration and drug side effects. Data were recorded on electronic media for statistical analysis. Significance was evaluated at p<0.05. RESULTS: Our study was conducted on 505 patients that were randomly selected, 309 (61.2%) males and 196 (38.8%) females. The mean age was 38.9±10.3 years. There were 313 (61.9%) participants who stopped smoking after treatment and 229 (45.3%) were not smoking currently. The smoking cessation rate of males (57.9%) was significantly lower than that of females (68.4%) (p=0.019). The rate of relapse of males (12.9%) was significantly lower than that of females (20.9%) (p=0.017). Side effects occurred in 68 (13.5%) patients, 32 taking varenicline and 36 taking bupropion. CONCLUSIONS: In our study, 45.3% of the patients had stopped smoking after one year. Smoking cessation rates were higher in the early stages of treatment than at late periods. Approximately half of the participants had never attended follow-up visits. Due to the low number of follow-up visits, both pharmacological treatment and motivational support were insufficient for effective smoking cessation therapy.